Differences in ability to perform activities of daily living among women with fibromyalgia:A cross-sectional study by von Bülow, Cecilie et al.
Syddansk Universitet
Differences in ability to perform activities of daily living among women with
fibromyalgia
A cross-sectional study
von Bülow, Cecilie; Amris, Kirstine; la Cour, Karen; Danneskiold-Samsøe, Bente; Wæhrens,
Eva Elisabet Ejlersen
Published in:
Journal of Rehabilitation Medicine
DOI:
10.2340/16501977-2021
Publication date:
2015
Document version
Publisher's PDF, also known as Version of record
Citation for pulished version (APA):
von Bülow, C., Amris, K., La Cour, K., Danneskiold-Samsøe, B., & Wæhrens, E. E. (2015). Differences in ability
to perform activities of daily living among women with fibromyalgia: A cross-sectional study. Journal of
Rehabilitation Medicine, 47(10), 941-947. DOI: 10.2340/16501977-2021
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 09. Sep. 2018
ORIGINAL REPORT
J Rehabil Med 2015; 47: 941–947
J Rehabil Med 47© 2015 The Authors. doi: 10.2340/16501977-2021
Journal Compilation © 2015 Foundation of Rehabilitation Information. ISSN 1650-1977
Objective: To investigate whether the Assessment of Motor 
and Process Skills (AMPS), the physical function subscales 
of the Fibromyalgia Impact Questionnaire (FIQ PF) and the 
36-item Short Form (SF-36 PF) can identify subgroups of 
women with fibromyalgia with clinically relevant differences 
in ability to perform activities of daily living. 
Design: Cross-sectional study. 
Subjects: A total of 257 women with fibromyalgia. 
Methods: Participants were evaluated with the AMPS (meas-
uring activities of daily living motor and activities of daily 
living process ability), FIQ and SF-36. AMPS independence 
cut-offs were used to divide the participants into 4 sub-
groups. Clinically relevant differences between subgroups 
were investigated based on the AMPS, FIQ PF and SF-36 PF. 
Result: Participants in the 4 AMPS-derived subgroups demon-
strated clinically relevant differences in observed activities 
of daily living motor and process ability. Neither the FIQ 
PF nor the SF-36 PF could differentiate between subgroups 
with clinically relevant differences in AMPS activities of dai-
ly living process ability.
Conclusion: Activities of daily living process skills reflect 
underlying organizational and adaptive capacities of the in-
dividual and are relevant targets for interventions aiming at 
improving activities of daily living ability. Since self-report 
instruments do not capture differences in activities of daily 
living process ability, clinicians should include observations-
based assessment of activities of daily living ability in order 
to individualize interventions offered.
Key words: ADL; functional ability; physical function; subgroup-
ing; AMPS; FIQ; SF-36; fibromyalgia; chronic widespread pain. 
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INTRODUCTION
The ability to perform activities of daily living (ADL) is a 
fundamental aspect of functional ability and a core outcome in 
clinical pain research and rheumatology (1, 2). The assessment of 
functional ability is traditionally based on patient-administered 
questionnaires (3–5). However, in studies of women with fibro-
myalgia (6–8), self-report has been complemented with observa-
tion-based evaluations of ADL ability. These observation-based 
evaluations were conducted with a standardized instrument, the 
Assessment of Motor and Process Skills (AMPS) (9). AMPS 
measures 2 aspects of ADL ability; ADL motor skills (moving 
self and objects) and ADL process skills (organizing time, space 
and objects and adapting actions) (9). A study involving 257 
women with fibromyalgia, recruited from a tertiary outpatient 
clinic, showed that approximately 95% of the women demon-
strated decreased ADL motor ability (i.e. below the AMPS ADL 
competence cut-off) and 40% demonstrated decreased ADL 
process ability as measured by the AMPS (7). That is, while 
women with fibromyalgia predominantly display ADL motor 
skill deficits, a fairly large proportion also demonstrates ADL 
process skill deficits, indicating different ADL ability profiles 
across patients (6, 7). The subgroup of women with ADL process 
skill deficits probably needs specific interventions designed to 
increase efficiency in organizing time, space and objects and 
adapting actions during ADL task performance, which suggests 
a need for differentiated interventions.
In order to provide differentiated interventions, clinicians 
need instruments that can identify clinically relevant differ-
ences in ADL task performance. Although the AMPS manual 
provides independence cut-offs for ADL motor and ADL 
process ability, it is unknown whether application of these 
cut-offs in women with fibromyalgia will result in subgroups 
in which the observed differences in ADL ability are of clinical 
relevance. In settings with limited access to observation-based 
evaluations of ADL ability it is of interest to determine whether 
self-report questionnaires can be used to differentiate between 
persons with clinically relevant differences in ADL ability. The 
Fibromyalgia Impact Questionnaire (FIQ) and 36-item Short 
Form (SF-36) are the most frequently used questionnaires 
in fibromyalgia populations. Both questionnaires contain a 
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physical function subscale used to evaluate ADL ability (10). 
However, these instruments do not provide cut-offs for differ-
ent levels of ADL ability. 
The aim of this study was two-fold; the first objective was to 
investigate whether sub-grouping of women with fibromyalgia 
based on the AMPS ADL motor and ADL process independ-
ence cut-offs would result in clinically relevant differences in 
the observed ADL ability across groups; the second objective 
was to investigate whether the women in the AMPS-derived 
subgroups demonstrated clinically relevant differences in self-
reported ADL ability when assessed with the FIQ and SF-36 
physical function subscales. 
MATERIAL AND METHODS
Study design and setting
For this cross-sectional study, participants were consecutively recruited 
from a tertiary outpatient clinic at the Department of Rheumatology, 
Frederiksberg Hospital, Denmark, from March 2007 to March 2009. 
Prior to entering an interdisciplinary rehabilitation programme, to 
which the participants had been referred, their ADL ability was evalu-
ated based on the AMPS, FIQ and SF-36. 
Participants
Females over 18 years of age and diagnosed with fibromyalgia accord-
ing to the 1990 American College of Rheumatology (ACR) classifica-
tion criteria (11), were considered eligible. Exclusion criteria were: 
concurrent psychiatric disorders not related to the pain disorder and 
not being fluent in Danish. 
Data sources and measurements
To characterize the participants’ disease severity and the overall impact 
of fibromyalgia, data from the FIQ pain and fatigue subscales and the 
FIQ total score were used (12). The SF-36 Physical Composite Score 
(PCS) and a Mental Composite Score (MCS) were used to characterize 
participants’ perceived health-related quality of life (13, 14). 
Assessment of Motor and Process Skills (AMPS).The AMPS (9) is a 
standardized observation-based assessment instrument used to measure 
the quality of ADL task performance. The AMPS has demonstrated 
sound psychometric properties when applied to women with chronic 
widespread pain, including fibromyalgia (6). The AMPS evaluation is 
conducted by a calibrated AMPS rater (an occupational therapist who 
has demonstrated valid and reliable administration and scoring of the 
AMPS). First, the AMPS rater performs an interview to identify ADL 
tasks of relevance to that person’s daily life (e.g. meal preparation and 
household management’s tasks). Then the person evaluated chooses 
and performs at least 2 well-known and relevant standardized ADL 
tasks of appropriate challenge. During the task performance the AMPS 
rater observes 2 domains of ADL task performance operationalized 
and defined through observable and goal-directed actions, i.e. 16 ADL 
motor skills and 20 ADL process skills (9). ADL motor skills are those 
actions a person performs in order to move self and task objects dur-
ing ADL task performance. ADL process skills are actions observed 
as the person: (i) selects, interacts with and uses tools and materials 
during task performance; (ii) logically carries out steps of an ADL 
task; and (iii) modifies the performance when problems occur. ADL 
motor skill deficits increase the demands on the ADL process skills 
that reflect underlying organizational and adaptive capacities of the 
individual (e.g. the ability to use compensatory strategies). Therefore 
the ADL process ability measure is a reflection of how effectively a 
person is currently able to organize and adapt actions to effect ADL 
task performance in a manner that is effortless, efficient, safe and 
independent (15).
When the AMPS rater has observed the performance of the 2 chosen 
standardized ADL tasks, the quality of the ADL task performance is 
scored according to criteria in the AMPS manual (9). Each ADL skill 
item is scored in terms of ease, efficiency, safety and independence 
using a 4-point ordinal rating scale. The AMPS rater uses a personal 
copy of a many-faceted Rasch-based computer-scoring software (16), 
to convert the ordinal ADL scores into 2 overall linear ADL ability 
measures; 1 for ADL motor ability and 1 for ADL process ability. 
These ADL ability measures are expressed in logistically transformed 
probability units adjusted for rater severity as well as ADL task and 
skill item difficulty (9, 17). The lower the person’s measure is on the 
ADL motor scale, the more clumsiness, physical effort, and/or fatigue 
the person is demonstrating during ADL task performance. The lower 
the person’s measure is on the ADL process scale, the less efficient 
the person is during ADL task performance (9). 
The ADL ability measures can be interpreted from a criterion-
referenced perspective by means of competence and independence. 
While the AMPS ADL competence cut-offs are used to identify persons 
demonstrating increased effort and/or efficiencies during ADL task 
performance, the independence cut-offs are used to predict persons in 
need of assistance to live in the community. As a previous study (7) 
showed that almost all women with fibromyalgia (95%) recruited from 
a tertiary setting had ADL motor ability measures below the ADL motor 
competence cut-off at 2.00 logits, it was decided to use the ADL motor 
and ADL process independence cut-offs for identifying different ADL 
ability profiles across subgroups. The ADL motor independence cut-off 
for determining need for assistance is 1.50 logits (sensitivity 0.67, speci-
ficity 0.72, i.e. 67% of an independent sample was correctly classified 
and 72% of a sample in need of assistance was correctly classified). 
Similarly, the ADL process independence cut-off for determining the 
need of assistance is 1.00 logits (sensitivity 0.81, specificity 0.70) (9). 
Evidence suggests that the ADL motor ability scale may be the most ac-
curate for predicting need for assistance in person with musculoskeletal 
conditions (18). However, the accuracy of the predictions are enhanced 
(83% correctly classified) when both the ADL motor and ADL process 
ability measures are below the independence cut-offs (9, 18). 
Fibromyalgia Impact Questionnaire (FIQ). FIQ is a disease-specific 
questionnaire, composed of 10 subscales, designed to evaluate how 
persons with fibromyalgia report their health status affected by the 
condition (FIQ total) (12). More severely impacted persons with 
fibromyalgia obtain a FIQ total score > 70 out of a maximum score of 
100 (19). The first item of the FIQ is the physical function (FIQ PF) 
subscale, used to evaluate a person’s perceived ability to perform 10 
tasks (shopping, laundry, preparing meals, washing dishes, vacuuming, 
making beds, walking several blocks, visiting friends, yard work, and 
driving a car). The responses are rated on a Likert scale from 0 = al-
ways able to do to 3 = never able to do. The responses are summed 
and divided by the number of valid scores and then standardized on 
a scale ranging from 0 to 10 (i.e. multiplied by 3.33). Ten indicates 
the highest level of disability. The subscales used to assess pain and 
fatigue are based on 100-mm visual analogue scales (12). 
36-item Short Form (SF-36). The SF-36 is a generic questionnaire 
composed of 8 subscales developed to assess health-related quality 
of life, expressed in a Physical Composite Score (PCS) and a Mental 
Composite Score (MCS) (20). The PCS and MCS ordinal scale scores 
are transformed into linear scales ranging from 0 to 100 and standardized 
to reflect a general population (US) mean of 50 (± 10). Measures of 0 
indicate the worst possible health status, and 100 is the best health status. 
The SF-36 physical function (SF-36 PF) subscale includes questions 
related to the following tasks; do vigorous and moderate activities, lift 
or carry groceries, climb 1 or several flights of stairs, make beds, walk 
1 block or more than 1 mile and bathe or dress. The questions on the 
SF-36 PF subscale are scored on a 3-point Likert scale from 1 = limited 
a lot to 3 = not limited at all. The raw scores are added and transformed 
to yield a single overall score for physical function, ranging from 0 to 
100. Low scores indicate that the person is limited a lot, and high scores 
indicate that the person performs all types of tasks (20). 
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Procedures
The FIQ and SF-36 were posted to the study population. Participants 
completed the questionnaires at home and were asked to return 
the completed questionnaires on the first day of the rehabilitation 
programme. AMPS raters from the Department of Occupational 
Therapy, Frederiksberg Hospital performed the AMPS evaluations at 
the outpatient clinic prior to the participants entering the rehabilita-
tion programme. Based on the AMPS evaluations participants were 
divided into 4 subgroups using the AMPS ADL motor and ADL process 
independence cut-offs. Group A: ADL motor ability < 1.50 logits and 
ADL process ability < 1.00 logits. Group B: ADL motor ability < 1.50 
logits and ADL process ability ≥ 1.00 logits. Group C: ADL motor 
ability ≥ 1.50 logits and ADL process ability < 1.00 logits. Group D: 
ADL motor ability ≥ 1.50 logits and ADL process ability ≥ 1.00 logits. 
Statistical analysis
The SPSS program version 19.0 (21) was used for statistical analysis. Nor-
mally distributed interval scale data were analysed using parametric statistics 
and reported in means and standard deviations (SD). Differences between 
subgroups were evaluated based on one-way analysis of variance (ANOVA). 
It was reasoned that the subgroups of women with higher levels of ADL 
motor ability measures would contain few participants and the statistically 
Table I. Baseline characteristics in the overall study population and study participants subgrouped based on Assessment of Motor and Process Skills 
(AMPS) independence cut-offs
Total Group A Group B Group C Group D 
Group 
difference* 
Significant differences 
between groups**
F; df; p-value Group Difference p-value
Participants, n (%) 257 (100) 93 (36) 116 (45) 14 (6) 34 (13)
Age, mean (SD) 45.39 (9.83) 46.11 (9.95) 46.18 (9.38) 47.65 (10.94) 39.76 (9.01) 422.72; 3; 
0.004
A/B
A/C
A/D
B/C
B/D
C/D
0.07
1.54
6.35
1.47
6.42
7.89
1.00
1.00
0.04
1.00
0.00
0.06
χ2; df; p-value Group Difference p-value
FIQ total, median 
Quartiles
Min–Max
61.97 
50.39–74.75
2.88–97.40
67.69 
55.93–79.78
12.70–97.40
60.72 
49.90–72.65
19.70–95.47
65.61 
45.54–78.31
14.76–95.00
51.85
35.97–64.99
2.88–80.89
18.13; 3; 
0.00
A/B
A/C
A/D
B/C
B/D
C/D
6.97
2.08
15.84
4.89
8.87
13.76
0.01
0.57
0.00
0.69
0.01
0.10
FIQ pain, median 
Quartiles
Min–Max
7.50 
5.80–8.60
0.00–10.00
8.00 
6.30–8.75
0.90–10.00
7.35 
5.65–8.50
0.20–10.00
7.20 
5.75–8.83
3.50–9.20
6.60
4.90–7.85
0.00–9.80
9.90; 3; 
0.019
A/B
A/C
A/D
B/C
B/D
C/D
0.65
0.80
1.40
0.15
0.75
0.60
0.05
0.81
0.00
0.85
0.08
0.35
FIQ fatigue, median 
Quartiles
Min–Max
8.60 
7.20–9.50
1.30–10.00
9.00 
8.10–9.58
2.80–10.00
8.40 
7.18–9.33
3.00–10.00
8.65 
6.43–9.83
1.30–9.90
7.90 
5.43–9.23
1.40–10.00
7.96; 3; 
0.047
A/B
A/C
A/D
B/C
B/D
C/D
0.60
0.35
1.10
0.25
0.50
0.75
0.03
0.63
0.01
0.87
0.22
0.51
SF-36 PCS, median 
Quartiles
Min–Max
26.71
22.57–30.94
8.79–50.68
25.78
21.87–30.47
8.79–40.79
26.62
22.60–30.51
11.02–43.78
30.68
27.42–34.02
20.49–34.02
28.63
23.03–34.64
14.70–50.68
10.27; 3; 
0.016
A/B
A/C
A/D
B/C
B/D
C/D
0.84
4.90
2.85
4.06
2.01
2.05
0.42
0.01
0.05
0.01
0.09
0.50
SF-36 MCS, median 
Quartiles
Min–Max
40.78
31.20–50.40
14.90–66.59
37.43
30.31–48.40
16.10–64.91
41.11
30.77–49.73
17.26–64.71
43.53
24.99–50.84
14.90–56.73
49.04
36.70–56.23
20.42-66.59
10.21; 3; 
0.017
A/B
A/C
A/D
B/C
B/D
C/D
3.68
6.10
11.61
2.42
7.93
5.51
0.43
0.87
0.00
0.73
0.01
0.06
*Group differences in age were analysed using analysis of variance (ANOVA), while groups differences on FIQ and SF-36 were analysed using the 
Kruskal–Wallis test. Statistically significant group differences were defined as p < 0.1.
**Multiple group comparisons in age were performed using Independent samples t-test, while multiple group comparisons on FIQ and SF-36 were 
performed using the Mann-Whitney U test. 
Statistically significant differences (in italic) in the post-hoc analyses were defined at p < 0.05.
AMPS: Assessment of Motor and Process Skills: FIQ: Fibromyalgia Impact Questionnaire: FIQ total: overall impact of the fibromyalgia. SF-36: 36-
item Short Form: PCS: Physical Composite Score: MCS: Mental Composite Score.
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significant differences between the 4 subgroups (A, B, C and D) were there-
fore defined at p < 0.1 in order to decrease the risk of type II error (failing to 
detect a difference). Thus, when the ANOVA yielded p < 0.1, multiple group 
comparisons were performed using Independent samples t-test. Skewed or 
ordinal scale data were analysed using non-parametric statistics and reported 
in medians, quartiles, minimum (min.) and maximum (max.) values. Dif-
ferences between subgroups were evaluated based on the Kruskal–Wallis 
test. Statistically significant subgroup differences were defined as p < 0.1. 
Thus, when the Kruskal–Wallis analyses yielded p < 0.1, multiple group 
comparisons were performed using the Mann-Whitney U test. Statistically 
significant differences in the post-hoc analysis were defined at p < 0.05.
In order to determine clinically relevant group differences in ob-
served ADL ability, the general guidelines described in the AMPS 
manual were applied (9). According to the AMPS manual a difference 
of ≥ 0.3 logits indicates a clinically relevant difference in ADL motor 
and/or ADL process ability (9). To determine clinically relevant group 
differences in self-reported ADL ability based on the FIQ PF and the 
SF-36 PF subscales, the criterion of a 0.5 SD was applied (22). In a 
comparable study sample a 0.5 SD equated to 1.12 points on the FIQ 
PF subscale and 10.00 points on the SF-36 PF subscale (23). 
RESULTS
Baseline characteristics of the 257 participants distributed 
into the 4 AMPS-derived subgroups A (n = 93), B (n = 116), 
C (n = 14) and D (n = 34) are shown in Table I. The majority 
(n = 209; 81%) of the participants was distributed into group A 
and B, based on an ADL motor ability measure below the 1.50 
logits independence cut-off. Only 13% of the participants were 
allocated to group D having an ADL motor ability measure 
≥ 1.50 logits and an ADL process ability measure ≥ 1.00 log-
its. Overall, the participants in group A reported higher levels 
of disease impact (FIQ total; p < 0.00), higher levels of pain 
(FIQ pain; p < 0.00) and fatigue (FIQ fatigue; p < 0.01), and 
lower levels of mental and physical health-related quality of 
life (SF-36 MCS; p < 0.00 and PCS; p < 0.05) compared with 
the participants in group D.
AMPS ADL ability measures, SF-36 PF and FIQ PF subscale 
scores for the total group and the 4 subgroups are shown in 
Table II. The Kruskal–Wallis test yielded overall statistically 
significant group differences in AMPS ADL motor (p < 0.00) 
and ADL process ability measures (p < 0.00). Post-hoc Mann-
Whitney U tests revealed statistically significant differences 
between groups with median AMPS ADL ability measures 
below and above the 1.50 logit ADL motor and the 1.00 logit 
ADL process independence cut-offs, respectively. Furthermore, 
these group differences were also clinically relevant (i.e. ≥ 0.3 
logits) (Table II). The Kruskal–Wallis test yielded overall 
statistically significant differences in the FIQ PF (p < 0.00) 
and the SF-36 PF (p < 0.00) subscale scores across groups. 
The differences between the median FIQ PF subscale score 
Table II. Group differences in ability to perform activities of daily living (ADL) when evaluated with the Assessment of Motor and Process Skills (AMPS), 
the 36-item Short Form physical function subscale (SF-36 PF) and the Fibromyalgia Impact Questionnaire physical function subscale (FIQ PF) (n = 257)
Total Group A Group B Group C Group D 
Group 
difference* 
Significant differences 
between groups**
χ2; df; p-value Group Difference p-value
AMPS 
Motor, median
Quartiles
Min–Max
1.07
0.74–1.41
0.04–2.82
0.91
0.48–1.14
0.04–1.48
1.06
0.73–1.27
0.06–1.49
1.65
1.57-1.78 
1.52-2.02
1.66
1.56- 1.94
1.50-2.82
121.65; 3; 0.00
A/B
A/C
A/D
B/C
B/D
C/D
0.15
0.74
0.75
0.59
0.60
0.01
0.01
0.00
0.00
0.00
0.00
0.77
AMPS process, median
Quartiles
Min–Max
1.09
0.85–1.26
0.12–2.18
0.81
0.65–0.89
0.12–0.99
1.23
1.11–1.44
1.00–2.18
0.84
0.77–0.96
0.53–0.98
1.37
1.22–1.58
1.05–.190
189.74; 3; 0.00 A/B
A/C
A/D
B/C
B/D
C/D
0.42
0.03
0.56
0.39
0.14
0.53
0.00
0.13
0.00
0.00
0.01
0.00
FIQ PF, median 
Quartiles
Min–Max
5.67 
3.73–7.00
0.00 – 9.00
6.25
4.46–7.41
0.00–9.00
5.56 
3.58–6.67
0.00–8.89
5.00 
3.48–7.17
0.67–9.00
4.51 
2.00–6.05
0.00–8.00
13.57; 3; 0.00 A/B
A/C
A/D
B/C
B/D
C/D
0.69
1.25
1.74
0.56
1.05
0.49
0.02
0.29
0.00
0.92
0.03
0.27
SF-36 PF, median 
Quartiles
Min–Max
40.00 
25.00–60.00
0.00–95.00
40.00 
25.00–52.50
0.00–80.00
40.00 
25.00–55.00
0.00–80.00
55.00 
37.50–71.25
22.22–85.00
55.00 
40.00–66.25
10.00–95.00
20.82; 3; 0.00 A/B
A/C
A/D
B/C
B/D
C/D
0.00
15.00
15.00
15.00
15.00
0.00
0.66
0.24
0.05
0.14
0.01
0.75
*Group differences in AMPS, FIQ PF and SF-36 PF were analysed using the Kruskal–Wallis test and statistically significant group differences were 
defined as p < 0.1.
**Multiple group comparisons in AMPS, FIQ and SF-36 were performed using the Mann-Whitney U test. 
The statistically significant differences (in italic) in the post-hoc analyses were determined by p < 0.05 and clinically relevant differences (in bold) 
were > 0.3 logits in AMPS and > 0.5 SD for the FIQ and SF-36.
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of participants in group A and participants in groups C and D 
(i.e. groups with median ADL motor ability measures below 
and above cut-off, respectively) were clinically relevant (i.e. 
> 0.5 SD). Finally, the differences between the median SF-
36 PF subscale scores of participants in groups A and B and 
participants in groups C and D were clinically relevant (i.e. 
> 0.5 SD) (Table II). Thus, the FIQ PF and SF-36 PF subscales 
could differentiate participants with clinically relevant dif-
ferences in AMPS ADL motor ability measures, but did not 
capture clinically relevant differences in AMPS ADL process 
ability, i.e. the questionnaires could not differentiate between 
participants in group A and B or between participants in group 
C and D, respectively. 
DISCUSSION
This is the first study to investigate whether women with fibro-
myalgia, classified into subgroups based on the AMPS ADL 
motor and ADL process independence cut-offs, demonstrate 
clinically relevant differences in observed ADL ability. Fur-
thermore, the study evaluated whether the most frequently used 
self-report instruments; the FIQ PF and SF-36 PF subscales 
could capture clinically relevant differences in ADL ability 
across the AMPS-derived subgroups. 
The study showed that subgrouping participants by AMPS 
independence cut-offs resulted in clinically relevant differences 
in observed ADL ability across all 4 subgroups. Thus, both the 
independence cut-off on the ADL motor and the ADL process 
scale of the AMPS could be used to divide the sample into 
subgroups with clinically relevant differences in ADL ability. 
By using the SF-36 PF subscale it was possible to differenti-
ate participants with AMPS ADL ability measures below and 
above the ADL motor independence cut-off. However, it could 
not differentiate participants in subgroups with similar levels of 
ADL motor ability, but different levels of ADL process ability. 
The FIQ PF subscale could differentiate participants with the 
lowest level of observed ADL ability (i.e. ability measures 
below both the ADL motor and ADL process independence 
cut-offs) from those with ability measures above the ADL 
motor independence cut-off. Thus, the FIQ PF subscale could 
not identify clinically relevant differences in ADL ability in 
participants with higher levels of ADL motor and/or ADL 
process ability. These findings are supported by a previous 
Rasch-based evaluation of the FIQ by Wolfe et al. (10), sug-
gesting that the FIQ PF subscale is inadequate for differenti-
ating between persons with intermediate disability scores, as 
the scale is non-linear, with compression in the middle and 
expansion at the ends of the scale.
Among the 3 instruments applied in this study, the FIQ PF 
subscale seemed the least useful to identify subgroups with 
clinically relevant differences in ADL ability. Both the SF-36 
PF subscale and the AMPS ADL motor scale could identify 
subgroups with clinically relevant differences in ADL motor 
ability. As both scales address physical aspects of ADL ability, 
for instance the ability to lift and carry objects (e.g. grocer-
ies) and mobility, they probably capture group differences in 
physical ADL ability. However, in a study by Amris et al. the 
SF-36 PF subscale and the AMPS ADL motor scale have been 
reported to correlate only moderately (r = 0.37, p = 0.000) (24). 
A potential explanation for this was that self-reported func-
tional ability assessed with the SF-36 PF subscale was more 
influenced by pain and persons’ psychosocial profiles, than 
that assessed with the observation-based AMPS ADL ability 
measures (25). Thus, it cannot be expected that the 2 scales 
identify the same aspects of ADL ability. 
Finally, the AMPS ADL process scale was the only scale 
that could be used to identify clinically relevant differences 
in ADL process ability in this sample. Almost half of the par-
ticipants (42%) had difficulties organizing and adapting their 
actions. The other half of the study population appeared more 
competent in using strategies making ADL task performance 
more effortless, efficient, safe and independent (15). This as-
pect of ADL ability was not captured by any of the self-report 
instruments. 
According to present and previous study findings (7, 25, 
26), “typical” women with fibromyalgia show increased physi-
cal effort and/or fatigue (i.e. decreased ADL motor ability) 
when performing relevant and familiar ADL tasks. Similar 
to a previous study population (7), approximately half of this 
study sample (42%), in addition to ADL motor skill deficits, 
showed inefficiencies (i.e. decreased ADL process ability) 
during ADL task performance, which enhanced the likelihood 
of needing assistance (9). That is, a rather large percentage of 
this population seems to be in need of interventions addressing 
their difficulties with organizing time, space and objects and 
adapting actions during ADL task performance. The results of 
this study suggest that the AMPS evaluation adds information 
of relevance to intervention planning, i.e. indicates whether 
intervention strategies need to address physical effort and/or 
inefficiencies during ADL task performance. For instance, if 
clinicians identify ADL process skill deficits in women with 
fibromyalgia, it could be relevant to offer interventions in 
which persons are taught how to organize and adapt ADL task 
performance as a means to overcome ADL motor skill deficits, 
and thus improve ADL ability. As the use of compensatory 
strategies has been shown to improve overall ADL ability and 
independence (27–29), it seems relevant for clinicians to con-
sider using a compensatory model in persons with fibromyalgia. 
The ability to differentiate intervention strategies to subgroups 
showing different organizational and adaptive capacities was 
not possible based on self-reported questionnaires in this study.
This study demonstrated that only a minority of the par-
ticipants had ADL motor and ADL process ability measures 
above the AMPS independence cut-offs. Participants in this 
subgroup were significantly younger and had lower levels of 
self-reported disease impact. As the severity of fibromyalgia 
may increase over time (30–32), these participants could be 
at risk of losing their current level of ADL ability. Clinicians 
might therefore need to consider the relevance of offering 
interventions focusing on maintaining or preventing loss of 
ADL ability when observing less pronounced ADL ability 
deficits in women with fibromyalgia. 
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Using an instrument that can identify different ADL abil-
ity profiles and specify ADL motor and/or ADL process skill 
deficits will probably assist in the delivery of interventions 
tailored to specific needs in different subgroups of women with 
fibromyalgia, and should thus improve functional outcomes. 
Based on the results of this study it seems reasonable to claim 
that the use of self-report questionnaires and observation-
based evaluations of ADL ability do not provide clinicians 
with the same type of information. The notion that self-report 
and observation-based assessments provide distinct and com-
plementary information is in accordance with findings from 
previous studies (6–8, 33–36). This supports the idea that clini-
cians should include observations-based assessment of ADL 
ability when planning the implementation of individualized 
interventions aiming at improving, maintaining or preventing 
loss of ADL ability in women with fibromyalgia. 
There are limitations to this study that should be considered 
when interpreting the results. The study sample only included 
women; however, as fibromyalgia mainly affects women this 
study reflects clinical practice. The participants were recruited 
from a tertiary outpatient clinic and might therefore not be 
representative of the overall referral population. The sample 
characteristics indicate that the participants represent the upper 
end of a pain severity spectrum in which the condition has a 
pronounced interference in everyday life. Thus, we only iden-
tified only a few participants who displayed ADL motor and 
ADL process ability measures above the AMPS independence 
cut-offs. However, as the AMPS identified clinically relevant 
differences across all the subgroups we consider the sample 
adequate. Finally, as this study took on an exploratory ap-
proach to investigate whether the AMPS ADL independence 
cutoff could be used to subgroup women with fibromyalgia, 
no methods aiming at controlling for the overall type I error 
rate was used. 
In conclusion, women with fibromyalgia can be divided 
into subgroups demonstrating clinically relevant differences 
in observed ADL ability based on the AMPS ADL motor and 
ADL process independence cut-offs. The most frequently used 
self-report instruments; the SF-36 PF and the FIQ PF subscales 
cannot substitute for observation-based assessment, as these 
questionnaires cannot identify clinically relevant group dif-
ferences in ADL process ability. ADL process skills reflect 
the underlying organizational and adaptive capacities of the 
individual and are relevant targets for interventions aiming at 
improving or maintaining overall ADL ability. It is therefore 
recommended to include observations-based assessment of 
ADL ability, such as the AMPS, in the clinical assessment of 
women with fibromyalgia when planning to individualize the 
interventions offered. 
The authors declare no conflicts of interest.
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